BPC-157 for Tendon Injuries
How It Works
Promotes angiogenesis, increases growth factor expression, and accelerates collagen synthesis in tendons.
Research Evidence
Multiple animal studies demonstrate accelerated tendon healing. Anecdotal human reports are extensive.
Dosing Protocol
250-500mcg daily, injected near the injury site or subcutaneously, for 4-8 weeks.
Important Considerations
- !No human clinical trials
- !WADA banned
- !Gray market quality concerns
- !Consult healthcare provider before use
- !Quality sourcing is critical
Frequently Asked Questions
Does BPC-157 work for tendon injuries?
Multiple animal studies demonstrate accelerated tendon healing. Anecdotal human reports are extensive. Research level: Animal studies show promise.
How does BPC-157 help with tendon injuries?
Promotes angiogenesis, increases growth factor expression, and accelerates collagen synthesis in tendons.
What is the BPC-157 dosage for tendon injuries?
250-500mcg daily, injected near the injury site or subcutaneously, for 4-8 weeks.
Is BPC-157 safe for tendon injuries?
Key considerations: No human clinical trials. WADA banned. Gray market quality concerns. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.
How long until BPC-157 works for tendon injuries?
Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.